Impact of inflammation on the osteoarthritic niche: implications for regenerative medicine
Impact of inflammation on the osteoarthritic niche: implications for regenerative medicine
Osteoarthritis (OA) is the most common form of arthritis worldwide and is the sixth leading cause of disability. It costs the UK economy approximately 1% of gross national product per annum. With an aging population, the cost of chronic conditions such as OA continues to rise. Historically, treatments for OA have been limited to painkillers, physiotherapy and joint injections. When these fail, patients are referred for joint replacement surgery. With the advent of tissue engineering strategies aimed at generating new bone and cartilage for repair of osteochondral defects, there has been considerable interest in exploiting these techniques to devise new treatments for OA. To date, little consideration has been given to the OA niche and attendant inflammatory milieu for any regenerative skeletal strategy. This review highlights the importance of understanding the osteoarthritic niche in order to modify existing tissue engineering and regenerative medicine strategies for the future treatment of OA.
cytokines, inflammation, osteoarthritis, regenerative medicine, tissue engineering
551-570
Williams, Emma L.
fbcdc734-fa2a-4741-9dd9-dab9413c6111
Edwards, Christopher J.
dcb27fec-75ea-4575-a844-3588bcf14106
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Oreffo, Richard O.C.
ff9fff72-6855-4d0f-bfb2-311d0e8f3778
July 2012
Williams, Emma L.
fbcdc734-fa2a-4741-9dd9-dab9413c6111
Edwards, Christopher J.
dcb27fec-75ea-4575-a844-3588bcf14106
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Oreffo, Richard O.C.
ff9fff72-6855-4d0f-bfb2-311d0e8f3778
Williams, Emma L., Edwards, Christopher J., Cooper, Cyrus and Oreffo, Richard O.C.
(2012)
Impact of inflammation on the osteoarthritic niche: implications for regenerative medicine.
Regenerative Medicine, 7 (4), .
(doi:10.2217/rme.12.34).
(PMID:22817628)
Abstract
Osteoarthritis (OA) is the most common form of arthritis worldwide and is the sixth leading cause of disability. It costs the UK economy approximately 1% of gross national product per annum. With an aging population, the cost of chronic conditions such as OA continues to rise. Historically, treatments for OA have been limited to painkillers, physiotherapy and joint injections. When these fail, patients are referred for joint replacement surgery. With the advent of tissue engineering strategies aimed at generating new bone and cartilage for repair of osteochondral defects, there has been considerable interest in exploiting these techniques to devise new treatments for OA. To date, little consideration has been given to the OA niche and attendant inflammatory milieu for any regenerative skeletal strategy. This review highlights the importance of understanding the osteoarthritic niche in order to modify existing tissue engineering and regenerative medicine strategies for the future treatment of OA.
This record has no associated files available for download.
More information
Published date: July 2012
Keywords:
cytokines, inflammation, osteoarthritis, regenerative medicine, tissue engineering
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 345789
URI: http://eprints.soton.ac.uk/id/eprint/345789
ISSN: 1746-0751
PURE UUID: 7979bc74-fc76-4637-b480-55d3ae73cac3
Catalogue record
Date deposited: 03 Dec 2012 15:34
Last modified: 18 Mar 2024 02:51
Export record
Altmetrics
Contributors
Author:
Emma L. Williams
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
